As shown for a variety of tumor entities, ADAM17 expression is upregulated in metastatic tumor cells, e.g., McGowan et al. found high ADAM17 expression in lymph node metastases compared with primary breast cancer, supporting the hypothesis that ADAM17 is involved in breast cancer progression [62]. The gene discussed is ADAM17; the disease is breast carcinoma.